Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Arginine vasopressin (AVP) plays a key role in many physiologic and pathologic processes. The most important stimulus for AVP release is a change in plasma osmolality. AVP is also involved in the response and adaptation to stress. Reliable measurement of AVP is hindered by several factors. Over 90% of AVP is tightly bound to platelets, and its estimation is influenced by the number of platelets, incomplete removal of platelets or pre-analytical processing steps. Copeptin (CTproAVP), a 39-aminoacid glycopeptide, is a C-terminal part of the precursor pre-provasopressin (pre-proAVP). Activation of the AVP system stimulates CTproAVP secretion into the circulation from the posterior pituitary gland in equimolar amounts with AVP. Therefore CTproAVP directly reflects AVP concentration and can be used as a surrogate biomarker of AVP secretion. In many studies CTproAVP represents AVP levels and its behavior represents changes in plasma osmolality, stress and various disease states, and shows some of the various physiologic and pathophysiologic conditions associated with increased or decreased AVP. Increased CTproAVP concentration is described in several studies as a strong predictor of mortality in patients with chronic heart failure and acute heart failure. Autosomal polycystic kidney disease (ADPKD) patients have both central and nephrogenic defects in osmoregulation and CTproAVP balance. A possibility raised by these clinical observations is that CTproAVP may serve to identify patients who could benefit from an intervention aimed at countering AVP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The brain and the stress axis: the neural correlates of cortisol regulation in response to stress
Dedovic, K., Duchesne, A., Andrews, J., Engert, V., & Pruessner, J. C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.074 · Cited by 699 · cited 1×
“Adaptation to stress stimuli, either acute or chronic, largely depends on the activation of the hypothalamic-pituitary-adrenal (HPA) axis and the catecholaminergic system [2].”
Catecholaminergic systems in stress: structural and molecular genetic approaches
Kvetnansky, R., Sabban, E. L., & Palkovits, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2006 · Cited by 548
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
(2003) · Critical Care · doi:10.1186/cc2337 · Cited by 356
Predictors of diabetes insipidus after transsphenoidal surgery: A review of 881 patients
Nemergut, E. C., Zuo, Z., Jane, J. A., & Laws, E. R. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.3.0448 · Cited by 313 · cited 1×
“It is estimated that 20%–30% of pituitary operations are associated with transient central DI, and that 2%–10% lead to permanent disease [20, 21].”
Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis
Corona, G., Giuliani, C., Parenti, G., Norello, D., Verbalis, J. G., Forti, G., Maggi, M., & Peri, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080451 · Cited by 301 · cited 1×
“A recent meta-analysis showed that a moderate reduction of serum sodium concentration is associated with an increased risk of death in different pathologic conditions [30].”
Self-citationPlasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Balanescu, S., Kopp, P., Gaskill, M. B., Morgenthaler, N. G., Schindler, C., & Rutishauser, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2499 · Cited by 246 · cited 1×
“The measurement of CTproAVP can be used to reflect AVP concentrations as it is produced in equimolar amounts as AVP and released into the circulation at the same time as AVP secretion [15].”
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214 · cited 1×
“Independent studies also have correlated CTproAVP concentration and albuminuria with renal decline in kidney transplant recipients [44].”
Plasma Vasopressin in Uncontrolled Diabetes Mellitus
Zerbe, R. L., Vinicor, F., & Robertson, G. L. (1979) · Diabetes · doi:10.2337/diab.28.5.503 · Cited by 158
THE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN
SPRUCE, B. A., MCCULLOCH, A. J., BURD, J., ØRSKOV, H., HEATON, A., BAYLIS, P. H., & ALBERTI, K. G. M. M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00145.x · Cited by 114
Cited by
Clària, J., Stauber, R. E., Coenraad, M. J., Moreau, R., Jalan, R., Pavesi, M., Amorós, À., Titos, E., Alcaraz‐Quiles, J., Oettl, K., et al. (2016) · Hepatology · doi:10.1002/hep.28740 · Cited by 763
Novel biomarkers for cardiovascular risk prediction.
Wang, J., Tan, G.-J., Han, L.-N., Bai, Y., He, M., & Liu, H. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.02.008 · Cited by 256
Rotondo, F., Butz, H., Syro, L. V., Yousef, G. M., Di Ieva, A., Restrepo, L. M., Quintanar-Stephano, A., Berczi, I., & Kovacs, K. (2016) · Pituitary · doi:10.1007/s11102-015-0703-0 · Cited by 93
Brain vasopressin signaling modulates aspects of maternal behavior in lactating rats
Bayerl, D. S., & Bosch, O. J. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12517 · Cited by 46
Neural basis for regulation of vasopressin secretion by anticipated disturbances in osmolality
Kim, A., Madara, J. C., Wu, C., Andermann, M. L., & Lowell, B. B. (2021) · eLife · doi:10.7554/elife.66609 · Cited by 25
Metadata
- Authors
- Bolignano, D., Cabassi, A., Fiaccadori, E., Ghigo, E., Pasquali, R., Peracino, A., Peri, A., Plebani, M., Santoro, A., Settanni, F., & Zoccali, C.
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2014-01-01
- Volume
- 52
- Issue
- 10
- Pages
- 1447-56
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2143195083
- Cited by
- 123
- References
- 11
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. https://app.cochat.ai/papers/10.1515/cclm-2014-0379
- The paper
- Bolignano, D., Cabassi, A., Fiaccadori, E., Ghigo, E., Pasquali, R., Peracino, A., Peri, A., Plebani, M., Santoro, A., Settanni, F., & Zoccali, C. (2014). Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2014-0379
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.